Navigation Links
Covance Central Laboratory Receives CAP Accreditation in China
Date:4/6/2009

- Covance's fourth CAP-accredited central laboratory advances patient safety, R&D efficiency -

PRINCETON, N.J., April 6 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that the company's Shanghai, China central laboratory has achieved accreditation by the College of American Pathologists (CAP). With CAP accreditation, Covance's Shanghai central laboratory joins an exclusive group of international laboratories that meet the highest standards of excellence to improve patient safety and speed drug development.

Based on rigorous accreditation standards, the CAP Laboratory Accreditation Program is the only internationally recognized program that utilizes teams of practicing laboratory professionals as inspectors. Designed to go well beyond regulatory compliance, the program helps laboratories achieve the highest standards of excellence to positively impact patient care.

The inspection process includes a quality practice blueprint for laboratories to follow, which is also used by inspection teams to assess the overall management and operation of the laboratory. Because of its comprehensive nature, CAP accreditation is designed to improve patient safety by advancing the quality of pathology and laboratory services through education, standard setting, and ensuring laboratories meet or exceed regulatory requirements.

Covance's Shanghai central laboratory is the company's fourth laboratory to achieve CAP accreditation and Level-1 NGSP (National Glycohemoglobin Standardization Program) certification, a standard requirement for drug development hemoglobin testing. Covance's central laboratory network includes dedicated facilities in Indianapolis, Indiana; Geneva, Switzerland; and Singapore. Each laboratory in Covance's network uses the same technical platforms, methods, and procedures to provide the same level of quality laboratory data, regardless of location.

"Covance is committed to meeting our clients' need for high quality laboratory data in all regions of the world," said Deborah Tanner, Covance's corporate senior vice president and president of central laboratory services. "With the combination of our broad, expanded portfolio of laboratory testing capabilities and CAP accreditation in China, Covance continues to provide the industry's most comprehensive and flexible clinical trial laboratory service solutions to the growing numbers of sponsors conducting clinical studies in the Asia Pacific region, and throughout the world."

The Shanghai laboratory opened in 2007 and currently offers routine chemistry, hematology, urinalysis, immunology, special chemistry, DNA extraction, flow cytometry, and coagulation testing services. Covance also operates two clinical development offices in Beijing and Shanghai that provide clients with access to large patient populations, investigators, and sites in this key region.

About Covance

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 9,600 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

Statements contained in this press release, which are not historical facts, are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including the statements contained herein regarding anticipated trends in the Company's business are based largely on management's expectations and are subject to an qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, levels of industry research and development spending, the Company's ability to continue to attract and retain qualified personnel, the fixed price nature of contracts or the loss of large contracts, and other factors described in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Covance to Present at the UBS Global Life Sciences Conference
2. Covance Elects Dr. Gary E. Costley to Board of Directors
3. Covance Agrees to Enter Strategic Relationship with eResearchTechnology to Offer its Clients eRTs Centralized Cardiac Safety Services
4. eResearchTechnology (eRT) Agrees to Acquire the Centralized ECG Business of Covance
5. eResearchTechnology, Inc. to Announce Agreement to Acquire the Centralized ECG Business of Covance
6. Covance and Care Partner on Rwanda Early Childhood Development Initiative
7. Wendel Barr Appointed Chief Operating Officer of Covance
8. Covance to Present at 26th Annual JPMorgan Healthcare Conference
9. Covance to Present at UBS Global Healthcare Services Conference
10. Covance to Present at Raymond James 29th Annual Institutional Investors Conference
11. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... is actively feeding the Frederick area economy by obtaining investment capital for emerging ... the past 2½ years that have already resulted in more than a million ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
Breaking Medicine Technology: